… Posterior uveitis that relapses despite aggressive treatment often causes permanent loss of
… and side effects of infliximab in patients with refractory relapsing chronic posterior uveitis. …

… clues to take into account for the optimal management of non-infectious intermediate uveitis,
posterior uveitis, and panuveitis along with uveitis-related sight-threatening complications. …

… systemic secondary effects associated with infliximab treatment, and patients complained
of … antibody infliximab is safe and efficient for the long-term treatment of posterior uveitis …

… , infliximab treatment showed long‐term effectiveness in patients with refractory posterior
uveitis … , and all showed improved inflammatory activity of the posterior pole. Furthermore, no …

… All 4 patients, 3 women and 1 man, had Behçet’s disease with severe posterior uveitis.They
had been treated in our departments for a mean of 2 years before infliximab treatment began.…

… posterior uveitis have been treated with at least four infusions of infliximab, a chimeric monoclonal
anti-TNF… infliximab infusions in 12 consecutive patients with BD and refractory bilateral …

… To determine the efficacy of infliximab treatment in refractory posterior uveitis in Behçet’s …
Four patients with posterior uveitis secondary to Behçet’s disease were treated with infliximab …

… to infliximab treatment with a reduction of the ocular inflammation and regression of retinal
neovascularization, but further investigations are necessary to evaluate the role of anti TNF-α …

… panuveitis or intermediate uveitis (HR, 5.37). Absence of some systemic medications before
… and has been reported with infliximab in the treatment of refractory uveitis.33, 43 We report a …

… Additionally, the use of anti-TNF is likely to be effective in active uveitis, as suggested by our
finding of an association between the number of uveitis flares before anti-TNF initiation and …